Ivabradine Hydrochloride Patent Expiration
Ivabradine Hydrochloride is Used for treating heart failure in humans. It was first introduced by Amgen Inc
Ivabradine Hydrochloride Patents
Given below is the list of patents protecting Ivabradine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Corlanor |
US7867996 (Pediatric) | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Jun 12, 2027 | Amgen Inc |
| Corlanor | US7867996 | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Dec 12, 2026 | Amgen Inc |
| Corlanor |
US7361649 (Pediatric) | β-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Aug 22, 2026 | Amgen Inc |
| Corlanor |
US7361650 (Pediatric) | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Aug 22, 2026 | Amgen Inc |
| Corlanor |
US7879842 (Pediatric) | Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Aug 22, 2026 | Amgen Inc |
| Corlanor | US7361649 | β-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Feb 22, 2026 | Amgen Inc |
| Corlanor | US7361650 | γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Feb 22, 2026 | Amgen Inc |
| Corlanor | US7879842 | Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | Feb 22, 2026 | Amgen Inc |
Ivabradine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List